Antisense modulation of fibroblast growth factor receptor 4 expression

Details for Australian Patent Application No. 2008308691 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Bhanot, Sanjay; Jain, Ravi; Yu, XingXian; Freier, Susan M.

Agent Pizzeys

Pub. Number AU-A-2008308691

PCT Pub. Number WO2009/046141

Priority 60/976,782 01.10.07 US

Filing date 1 October 2008

Wipo publication date 9 April 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/046141 Priority application(s): WO2009/046141

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008308697-Imageable rodent model of asthma

2008308686-Modular point-of-care devices and uses thereof